These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33791156)

  • 1. Screening strategy of TMPRSS2 inhibitors by FRET-based enzymatic activity for TMPRSS2-based cancer and COVID-19 treatment.
    Chen Y; Huang WC; Yang CS; Cheng FJ; Chiu YF; Chen HF; Huynh TK; Huang CF; Chen CH; Wang HC; Hung MC
    Am J Cancer Res; 2021; 11(3):827-836. PubMed ID: 33791156
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Salleh MZ; Deris ZZ
    Life (Basel); 2022 Feb; 12(2):. PubMed ID: 35207518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Enzymatic TMPRSS2 Assay for Assessment of Clinical Candidates and Discovery of Inhibitors as Potential Treatment of COVID-19.
    Shrimp JH; Kales SC; Sanderson PE; Simeonov A; Shen M; Hall MD
    bioRxiv; 2020 Aug; ():. PubMed ID: 32596694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural insights and inhibition mechanism of TMPRSS2 by experimentally known inhibitors Camostat mesylate, Nafamostat and Bromhexine hydrochloride to control SARS-coronavirus-2: A molecular modeling approach.
    Sonawane KD; Barale SS; Dhanavade MJ; Waghmare SR; Nadaf NH; Kamble SA; Mohammed AA; Makandar AM; Fandilolu PM; Dound AS; Naik NM; More VB
    Inform Med Unlocked; 2021; 24():100597. PubMed ID: 34075338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BC-11 is a covalent TMPRSS2 fragment inhibitor that impedes SARS-CoV-2 host cell entry.
    Moumbock AFA; Tran HTT; Lamy E; Günther S
    Arch Pharm (Weinheim); 2023 Jan; 356(1):e2200371. PubMed ID: 36316225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tannic acid suppresses SARS-CoV-2 as a dual inhibitor of the viral main protease and the cellular TMPRSS2 protease.
    Wang SC; Chen Y; Wang YC; Wang WJ; Yang CS; Tsai CL; Hou MH; Chen HF; Shen YC; Hung MC
    Am J Cancer Res; 2020; 10(12):4538-4546. PubMed ID: 33415017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous binding of potential COVID-19 drugs (Camostat and Nafamostat) to human serine protease TMPRSS2.
    Zhu H; Du W; Song M; Liu Q; Herrmann A; Huang Q
    Comput Struct Biotechnol J; 2021; 19():467-476. PubMed ID: 33505639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Enzymatic TMPRSS2 Assay for Assessment of Clinical Candidates and Discovery of Inhibitors as Potential Treatment of COVID-19.
    Shrimp JH; Kales SC; Sanderson PE; Simeonov A; Shen M; Hall MD
    ACS Pharmacol Transl Sci; 2020 Oct; 3(5):997-1007. PubMed ID: 33062952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells.
    Mahoney M; Damalanka VC; Tartell MA; Chung DH; Lourenco AL; Pwee D; Mayer Bridwell AE; Hoffmann M; Voss J; Karmakar P; Azouz N; Klingler AM; Rothlauf PW; Thompson CE; Lee M; Klampfer L; Stallings C; Rothenberg ME; Pöhlmann S; Whelan SP; O'Donoghue AJ; Craik CS; Janetka JW
    bioRxiv; 2021 May; ():. PubMed ID: 34131661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based drug repositioning over the human TMPRSS2 protease domain: search for chemical probes able to repress SARS-CoV-2 Spike protein cleavages.
    Singh N; Decroly E; Khatib AM; Villoutreix BO
    Eur J Pharm Sci; 2020 Oct; 153():105495. PubMed ID: 32730844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtual drug repurposing study against SARS-CoV-2 TMPRSS2 target.
    DurdaĞi S
    Turk J Biol; 2020; 44(3):185-191. PubMed ID: 32595355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A quantum chemical study on the anti-SARS-CoV-2 activity of TMPRSS2 inhibitors.
    Kondo A; Fujimoto KJ; Yanai T
    Phys Chem Chem Phys; 2023 Aug; 25(30):20597-20605. PubMed ID: 37477571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TMPRSS2 and SARS-CoV-2 SPIKE interaction assay for uHTS.
    Cicka D; Niu Q; Qui M; Qian K; Miller E; Fan D; Mo X; Ivanov AA; Sarafianos SG; Du Y; Fu H
    J Mol Cell Biol; 2023 Aug; 15(3):. PubMed ID: 36921991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational screening of camostat and related compounds against human TMPRSS2: A potential treatment of COVID-19.
    Sharma T; Baig MH; Khan MI; Alotaibi SS; Alorabi M; Dong JJ
    Saudi Pharm J; 2022 Mar; 30(3):217-224. PubMed ID: 35095307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease-Responsive Potential-Tunable AIEgens for Cell Selective Imaging of TMPRSS2 and Accurate Inhibitor Screening.
    Cheng Y; Clark AE; Yim W; Borum RM; Chang YC; Jin Z; He T; Carlin AF; Jokerst JV
    Anal Chem; 2023 Feb; 95(7):3789-3798. PubMed ID: 36753444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19.
    Hu X; Shrimp JH; Guo H; Xu M; Chen CZ; Zhu W; Zakharov AV; Jain S; Shinn P; Simeonov A; Hall MD; Shen M
    ACS Pharmacol Transl Sci; 2021 Jun; 4(3):1124-1135. PubMed ID: 34136758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid drug-screening strategy identifies potential SARS-CoV-2 cell-entry inhibitors targeting human transmembrane serine protease.
    Feng Y; Cheng X; Wu S; Mani Saravanan K; Liu W
    Struct Chem; 2022; 33(5):1503-1515. PubMed ID: 35571866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic block of SARS-CoV-2 infection by combined drug inhibition of the host entry factors PIKfyve kinase and TMPRSS2 protease.
    Kreutzberger AJB; Sanyal A; Ojha R; Pyle JD; Vapalahti O; Balistreri G; Kirchhausen T
    bioRxiv; 2021 Aug; ():. PubMed ID: 34100014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Suite of TMPRSS2 Assays for Screening Drug Repurposing Candidates as Potential Treatments of COVID-19.
    Shrimp JH; Janiszewski J; Chen CZ; Xu M; Wilson KM; Kales SC; Sanderson PE; Shinn P; Itkin Z; Guo H; Shen M; Klumpp-Thomas C; Michael SG; Zheng W; Simeonov A; Hall MD
    bioRxiv; 2022 Feb; ():. PubMed ID: 35169799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TMPRSS2 inhibitor discovery facilitated through an
    Peiffer AL; Garlick JM; Wu Y; Soellner MB; Brooks CL; Mapp AK
    bioRxiv; 2021 Mar; ():. PubMed ID: 33791707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.